Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)

Veeda Biopharma: A fully
Integrated Biopharma Division
of Veeda Clinical Research

Veeda Biopharma: A fully Integrated Biopharma Division of Veeda Clinical Research





Customized Integrated Solutions for Your
Distinctive Biopharma Assets



Clinical Bioanalytical Solutions

  1. Vaccines (Bacterial/Viral)

    1. Primary and Secondary end-point analysis, Neutralizing Antibody Assays, Serum Bactericidal Assays

  2. Biologics

    1. Peptides/Proteins/
      Novel Biologics

    2. Biosimilars/Bio-betters

    1. Pharmacokinetic/Pharmacodynamic Analysis, Anti-drug Antibody Assays, Neutralizing Antibody Assays Biomarker Analysis

Non-Clinical Characterization Solutions

  1. Bioprocess

    1. Upstream/ Downstream: Lab-scale Manufacturing and Purification, Cell-line Characterization and Qualification

  2. Discovery Biology

    1. Assay Biology, Functional Characterization & DMPK/ADME

  3. Analytical Characterization

    1. Physicochemical Characterization, Higher Order Structure, High throughput Characterization, Analytical Services






Our Infrastructure

BD-FACS

MSD

LC-MS Orbitrap

HR-MS (QTof)

LCMS Sciex (QQQ)

DLS

DSC

FTIR

CD

SEC/FFF- MALS

CE

Cytiva Biacor SPR 1S+

Luminex Multiplex System

Agilent Novocyte




Related Information

Brochure on: Biosimilar and Large Molecule Development Capabilities
Podcast: Addressing Key Challenges of Conducting First Monoclonal Antibody (Omalizumab Study)
Symposium: Integrated Phase I Trial Solutions for Emerging Biopharmas; Addressing Development Challenges, and Accelerating




Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.